This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Spotlight Innovation Inc.
Drug Names(s): STL 182, STL182
Description: STL-182 is an orally-available small molecule that may restore neuromuscular function by stabilizing endogenous Survival of Motor Neuron (SMN) protein.
Pink Sheet Weekly Trademark Review Oct. 13, 2015
Additional information available to subscribers only: